Ras suppressor-1 (RSU1), originally described as a suppressor of Ras oncogenic transformation, localizes to focal adhesions interacting with the ILK-PINCH-PARVIN (
IPP) complex that exerts a well-established oncogenic role in
cancer. However, RSU1 implication in
lung cancer is currently unknown. Our study aims to address the role of RSU1 in
lung adenocarcinoma (LUADC). We here show that RSU1
protein expression by immunohistochemistry is downregulated in LUADC human tissue samples and represents a significant prognostic
indicator. In silico analysis of gene chip and
RNA seq data validated our findings. Depletion of RSU1 by
siRNA in
lung cancer cells promotes anchorage-independent cell growth, cell motility and epithelial to mesenchymal transition (EMT). Silencing of RSU1 also alters
IPP complex expression in
lung cancer cells. The p29 RSU1 truncated
isoform is detected in
lung cancer cells, and its expression is downregulated upon RSU1 silencing, whereas it is overexpressed upon ILK overexpression. These findings suggest that RSU1 exerts a
tumor suppressive role with prognostic significance in LUADC.